Roche overhauls Spark gene therapy unit, recording $2.4B in full impairment
10th March 2025 Uncategorised 0Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit that the Swiss pharma bought for $4.3 billion in 2019.
More: Roche overhauls Spark gene therapy unit, recording .4B in full impairment
Source: fierce